| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2023 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 2,500 | $200.00 | $500,000.00 | -11.4% | -11.9% | -11.0% | |
| Dec 14, 2023 | LQDA Liquidia Corp | Caligan Partners LP58 | Director, 10% Owner, See Remarks | Buy | 1,117,318 | $7.16 | $7,999,996.88 | +11.0% | +102.1% | +49.8% | |
| Dec 14, 2023 | LQDA Liquidia Corp | Manning Paul B54 | Director | Buy | 279,330 | $7.16 | $2,000,002.80 | New | +102.1% | +49.8% | |
| Dec 13, 2023 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Jacobs Bette | Director | Sell | 4,157 | $0.46 | $1,925.52 | -13.3% | -9.9% | -81.4% | |
| Dec 13, 2023 | SHPH Shuttle Pharmaceuticals Holdings, Inc. | Brown Milton | Director | Sell | 2,921 | $0.46 | $1,353.01 | -0.3% | -9.9% | -81.4% | |
| Dec 13, 2023 | LNTH Lantheus Holdings, Inc. | Sabens Andrea47 | Chief Accounting Officer | Sell | 341 | $75.62 | $25,786.42 | -0.6% | -20.5% | +20.0% | |
| Dec 13, 2023 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 10,000 | $0.73 | $7,268.00 | +10.9% | +54.9% | -6.6% | |
| Dec 12, 2023 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 13,925 | $120.30 | $1,675,240.06 | -19.1% | +13.9% | +5.4% | |
| Dec 12, 2023 | UTHR United Therapeutics Corp | Causey Christopher59 | Director | Sell | 3,000 | $249.68 | $749,034.00 | -39.6% | -0.9% | +43.9% | |
| Dec 12, 2023 | AMRN Amarin Corp Plc\uk | Ketchum Steven B | Chief Scientific Officer | Sell | 34,131 | $0.79 | $26,963.49 | -5.7% | +13.5% | -40.4% | |
| Dec 11, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 10,000 | $1.53 | $15,310.00 | - | - | - | |
| Dec 11, 2023 | ANIP Ani Pharmaceuticals Inc | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $49.21 | $12,302.50 | -0.7% | +31.5% | +17.6% | |
| Dec 11, 2023 | CBSTF Cannabist Co Holdings Inc. | Vita Nicholas | Chief Executive Officer | Sell | 550,000 | $0.39 | $211,755.00 | -0.9% | - | - | |
| Dec 11, 2023 | MIRA Mira Pharmaceuticals, Inc. | McNulty Brian Patrick88 | - | Sell | 238,095 | $3.05 | $726,087.98 | -0.6% | -2.6% | -18.8% | |
| Dec 8, 2023 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 77,679 | $120.37 | $9,350,350.23 | -30.5% | +15.4% | +9.3% | |
| Dec 8, 2023 | EOLS Evolus, Inc. | Moatazedi David68 | See Remarks | Sell | 82,648 | $9.95 | $822,395.97 | -6.3% | +51.2% | +29.4% | |
| Dec 7, 2023 | KNSA Kiniksa Pharmaceuticals International, Plc | Paolini John F.51 | Chief Medical Officer | Sell | 28,600 | $17.65 | $504,758.39 | -12.0% | +18.0% | +20.8% | |
| Dec 7, 2023 | GSK Gsk Plc | Gsk Plc | 10% Owner | Buy | 3,300,000 | $5.00 | $16,500,000.00 | +30.9% | +18.4% | -4.0% | |
| Dec 7, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $238.89 | $1,433,330.59 | -7.6% | -2.1% | +52.7% | |
| Dec 7, 2023 | TXMD Therapeuticsmd, Inc. | Walker Marlan D81 | Chief Executive Officer | Sell | 19,050 | $2.29 | $43,683.90 | -12.8% | +10.9% | -44.3% | |
| Dec 6, 2023 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 8,396 | $120.03 | $1,007,780.28 | -22.1% | +11.9% | +5.8% | |
| Dec 6, 2023 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 20,830 | $119.86 | $2,496,648.39 | -36.7% | +11.9% | +5.8% | |
| Dec 6, 2023 | TSNDF Terrascend Corp. | Jw Asset Management, LLC65 | Executive Chairman | Buy | 10,000 | $1.59 | $15,855.00 | - | - | - | |
| Dec 6, 2023 | HIMS Hims & Hers Health, Inc. | Baird Melissa | Chief Operating Officer | Sell | 27,399 | $8.87 | $243,108.59 | -2.3% | +60.0% | +255.1% | |
| Dec 5, 2023 | CBSTF Cannabist Co Holdings Inc. | Clarke Jeff | - | Sell | 124,220 | $0.35 | $43,228.56 | -15.0% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.